Seven Bridges Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,674
Closed -$270K 151
2016
Q4
$270K Sell
3,674
-1,732
-32% -$129K 0.28% 91
2016
Q3
$434K Sell
5,406
-1,554
-22% -$124K 0.39% 66
2016
Q2
$548K Buy
+6,960
New +$524K 0.47% 58

Other funds holding LLY

Seven Bridges Advisors's LLY Position: Q1 2017 in Review

Seven Bridges Advisors sold out of Eli Lilly (LLY) in Q1 2017, closing a stake of 3,674 shares — an estimated $270K sold.

Seven Bridges Advisors first reported a position in LLY in Q2 2016 and held it in 3 quarters. The position peaked at $548K in Q2 2016. 1,249 funds tracked by Wall St. Rank hold LLY as of Q1 2017.

  • Seven Bridges Advisors reported no remaining Eli Lilly position as of Q1 2017 after selling out during the quarter.
  • Seven Bridges Advisors sold 3,674 Eli Lilly shares in Q1 2017, an estimated $270K.
  • Seven Bridges Advisors first reported a position in Eli Lilly in Q2 2016 and held it in 3 quarters.
  • Seven Bridges Advisors's Eli Lilly position peaked at $548K in Q2 2016.
  • 1,249 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.

Based on Seven Bridges Advisors's 13F filing for Q1 2017, filed 15 May 2017.